ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,356,234 | -61.6% | 34,318 | -60.9% | 0.31% | -80.0% |
Q3 2022 | $3,531,000 | -4.4% | 87,877 | 0.0% | 1.54% | +72.1% |
Q2 2022 | $3,694,000 | +7.9% | 87,877 | 0.0% | 0.90% | -20.5% |
Q1 2022 | $3,424,000 | -2.2% | 87,877 | 0.0% | 1.13% | +60.9% |
Q4 2021 | $3,502,000 | +6.3% | 87,877 | -3.6% | 0.70% | -39.1% |
Q3 2021 | $3,295,000 | -11.8% | 91,170 | 0.0% | 1.15% | -6.7% |
Q2 2021 | $3,737,000 | -8.5% | 91,170 | -2.7% | 1.23% | -15.8% |
Q1 2021 | $4,086,000 | -13.8% | 93,670 | -1.1% | 1.46% | -13.7% |
Q4 2020 | $4,738,000 | – | 94,670 | – | 1.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
Brown University | 381,759 | $19,107,000 | 13.82% |
Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |